Health technology company Detect announced on Friday that it had received emergency clearance from the Food and Drug Administration for its COVID-19 molecular test at home.
The detect test uses an app to help users run and interpret their results. The company said it is also working on an electronic passport system with a telehealth service so that its offering can be used for travel and events.
“The Detect COVID-19 test brings laboratory accuracy into the house, helps to mitigate the transmission of COVID-19 and to make everyday activities safe and fear-free again,” said Dr. Jonathan Rothberg, Founder of Detect, in a statement.
“As a complement to vaccines, high-precision, rapid tests will be vital as the pandemic becomes endemic. We developed the Detect COVID-19 Test to help people get back to doing the things they love, with the people they love, in the safest possible way. “
WHY IT IS IMPORTANT
Detect is introducing its COVID-19 test as a more accurate option that can be done at home in an hour without the need for laboratory analysis.
The company said the Detect test showed an overall match of 97.3% with a Polymerase chain reaction (PCR) test, usually done in a laboratory.
Most home tests are Antigen tests that take less time to get results but may be less accurate than a molecular test.
THE BIGGER TREND
Other manufacturers of COVID-19 home tests include: Ellume, Cue Health, Lucira and Abbott.
Rapid COVID-19 tests at home have been in short supply in the US over the past few months, and trial prices may vary.
At the beginning of this month the Biden administration announced that it would allocate an additional $ 1 billion to purchase rapid tests in response to the shortage.